Navigation Links
Irvine Scientific Launches IS CHO-CD XP(TM)
Date:3/6/2009

SANTA ANA, Calif., March 6 /PRNewswire/ -- Irvine Scientific, a leading medical device/biopharmaceutical company located in Santa Ana, California, is proud to announce the addition of IS CHO-CD XP(TM) Culture System to their cell culture product line. IS CHO-CD XP(TM) Culture System is a set of chemically-defined*, serum-free, and animal component free media designed using metabolic-balancing technology to deliver robust cell growth and production for recombinant CHO cell lines. It supports batch, fed-batch, and perfusion culture processes.

The IS CHO-CD XP(TM) Culture System is made up of IS CHO-CD XP(TM) growth medium, IS CHO Feed-CD XP medium, and IS Hydrolysate Blend XP(TM) supplement. All components are fully compatible with other IS CHO products and are available in liquid or powder formats.

With over three decades of life-science innovation Irvine Scientific has expertise in developing world-class cell culture media for the biopharmaceutical industry. They are industrial-scale media manufacturers with a capacity of 800,000 kg/yr (~40 million liters) and continue to be leaders in rapid turnaround time worldwide. Irvine Scientific's ongoing personal service, technical support, and accessibility to key team members ensure that your questions and concerns are addressed every step of the way. Their cGMP facility was the first media manufacturing facility to receive ISO 13485:2003 certification. At Irvine Scientific their staff is virtually an extension of yours.

For more information on Irvine Scientific, visit our website at www.irvinesci.com/xp or contact: Nancy Huezo at nhuezo@irvinesci.com. Phone (800) 437-5706 or (949) 261-7800 ext 238.

*Chemically-defined when used without the Hydrolysate Blend.

    Contact:    Nancy Huezo
                Associate Product Manager
                800 437 5706 / 949 261 7800 ext 238
                nhuezo@irvinesci.com


'/>"/>
SOURCE Irvine Scientific
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Edwards Lifesciences Grants UC Irvine $5 Million to Establish the Edwards Lifesciences Center for Advanced Cardiovascular Technology
2. BioMed Realty Trust Appoints Executive Officer of the Irvine Company to Its Board
3. Families of Spinal Muscular Atrophy; University of California, Irvine Stem Cell Scientist; and California Stem Cell Announce Collaboration for Safety Studies for Stem Cell Therapy in Spinal Muscular Atrophy
4. Irvine Dermatologist Begins In-office Clinical Studies -- Nissan Pilest, MD Combines Multi-Use Botox in Laser Resurfacing Clinical Studies
5. Boston Scientific to Explore Sale of Cardiac Surgery and Vascular Surgery Businesses
6. Thermo Fisher Scientific Executive Officers Adopting SEC Rule 10b5-1 Trading Programs
7. Kewaunee Scientific Announces First Quarter Results and Quarterly Dividend
8. Ralf Rosskamp, M.D. Joins Biodels Scientific Advisory Board
9. Boston Scientific Amends Credit Facility and Prepays $1 Billion on Loan
10. Magellan Biosciences Names Steven E. Diamond, PhD, Chief Scientific Officer
11. Thermo Fisher Scientific to Present at Investor Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/25/2017)... ... April 25, 2017 , ... Franz ... Lisp (CL) development tools, and market leader for Semantic Graph Database ... now available within the most effective system for developing and deploying applications to ...
(Date:4/25/2017)... ... ... Leaders of Quorum Review IRB and Kinetiq , the consulting ... Association of Clinical Research Professionals (ACRP) 2017 Meeting & Expo with topics ... excited to present subject matter expertise on topics that impact the global clinical research ...
(Date:4/21/2017)... , ... April 21, 2017 , ... ... Webster Bank, today announced first round funding to three startups through the UConn ... financial support to new business startups affiliated with UConn. , The UConn Innovation ...
(Date:4/20/2017)... ... April 20, 2017 , ... As ... webinar will explore challenging patient cases when screening for direct oral anticoagulant. When ... be a need for bridging parental anticoagulation especially for those at high risk ...
Breaking Biology Technology:
(Date:4/3/2017)... 3, 2017  Data captured by IsoCode, ... detected a statistically significant association between the ... treatment and objective response of cancer patients ... predict whether cancer patients will respond to ... well as to improve both pre-infusion potency testing ...
(Date:3/29/2017)... , March 29, 2017  higi, the health IT ... North America , today announced a ... the acquisition of EveryMove. The new investment and acquisition ... of tools to transform population health activities through the ... data. higi collects and secures data today ...
(Date:3/24/2017)... Research and Markets has announced the addition of the ... Industry Forecast to 2025" report to their offering. ... The Global Biometric Vehicle Access ... 15.1% over the next decade to reach approximately $1,580 million by ... and forecasts for all the given segments on global as well ...
Breaking Biology News(10 mins):